US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 36.000
  • +1.280+3.69%
Close Jun 3 16:00 ET
  • 36.410
  • +0.410+1.14%
Post 18:20 ET
640.66MMarket Cap-642P/E (TTM)

About Cartesian Therapeutics Company

Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company is headquartered in Gaithersburg, MD.

Company Profile

SymbolRNAC
Company NameCartesian Therapeutics
Listing DateJun 22, 2016
CEODr. Carsten Brunn, PhD
MarketNASDAQ
Employees38
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address704 Quince Orchard Road
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Websitehttp://www.cartesiantherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Carsten Brunn, PhD
  • Director, President and Chief Executive Officer
  • 6.11M
  • Dr. Christopher M. Jewell, PhD
  • Chief Scientific Officer
  • 53.10K
  • Dr. Milos Miljkovic, M.D.
  • Chief Medical Officer
  • --
  • Blaine Davis
  • Chief Financial Officer and Principal Accounting Officer
  • 2.49M
  • Dr. Metin Kurtoglu, M.D.,PhD
  • Chief Technology Officer
  • 5.37K
  • Dr. Emily English, PhD
  • Senior Vice President and Head of Manufacturing
  • --
  • Carrie S. Cox
  • Chairman of the Board
  • 292.32K
  • Dr. Timothy A. Springer, M.D.,PhD
  • Director
  • 192.73K
  • Timothy C. Barabe
  • Independent Director
  • 212.93K
  • Dr. Michael Singer, M.D.,PhD
  • Independent Director
  • 5.71K
  • Dr. Nishan de Silva, M.B.A.,M.D.
  • Independent Director
  • 188.58K
  • Dr. Murat Kalayoglu, M.D.,PhD
  • Independent Director
  • --
  • Patrick J. Zenner
  • Independent Director
  • 192.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.46%